Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study (Q39949914)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study |
scientific article |
Statements
1 reference
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study (English)
1 reference
Giovanni Scambia
1 reference
Giancarlo Agnelli
1 reference
Gualberto Gussoni
1 reference
Melina Verso
1 reference
Mario Mandalà
1 reference
Luigi Cavanna
1 reference
Sandro Barni
1 reference
Franco Buzzi
1 reference
Rodolfo Passalacqua
1 reference
Sergio Ricci
1 reference
Giampietro Gasparini
1 reference
Vito Lorusso
1 reference
Erminio Bonizzoni
1 reference
Maurizio Tonato
1 reference
PROTECHT Investigators
1 reference
31 August 2009
1 reference
1 reference
Identifiers
1 reference